Inflammatory and Autoimmune Diseases

Lines of Research

01.Inflammatory and Autoimmune Diseases
02.Microbiota in inflammatory diseases
03.Cardiovascular risk in inflammatory diseases
04.Nursing care in osteoarticular diseases

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

Cruz, BH; Alonso, F; Alen, JC; Pego-Reigosa, JM; Lopez-Longo, FJ; Galindo-Izquierdo, M; Olive, A; Tomero, E; Horcada, L; Uriarte, E; Erausquin, C; Sanchez-Atrio, A; Montilla, C; Soler, GS; Fernandez-Nebro, A; Blanco, R; Rodriguez-Gomez, M; Vela, P; Freire, M; Diez-Alvarez, E; Boteanu, AL; Narvaez, J; Taboada, VM; Ruiz-Lucea, E; Andreu, JL; Fernandez-Berrizbeitia, O; Hernandez-Beriain, JA; Gantes, M; Perez-Venegas, JJ; Ibanez-Barcelo, M; Pecondon-Espanol, A; Marras, C; Bonilla, G; Castellvi, I; Moreno, M; Raya, E; Vila, VEQ; Vazquez, T; Ruan, JI; Munoz, S; Rua-Figueroa, I – 2020

Digestive involvement in primary Sjogren’s syndrome: analysis from the Sjogrenser registry

Melchor, S; Sanchez-Piedra, C; Castro, MF; Andreu, JL; Taboada, VM; Olive, A; Rosas, J; Menor, R; Garcia-Aparicio, A; Longo, FJL; Manrique-Arija, S; Vadillo, JAG; Lopez-Gonzalez, R; Narvaez, J; Galisteo, C; Martin, JG; Naranjo, A; Illera, O; Moreira, B; Raya, E; Lopez, MR; Judez, E; Moriano, C; Torrente-Segarra, V; Magallon, BG; Astete, CG; Castellvi, I; Bohorquez, C; Loricera, J; Belzunegui, J; Carreira, PE – 2020

Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

Cobo-Ibanez, T; Urruticoechea-Arana, A; Rua-Figueroa, I; Martin-Martinez, MA; Ovalles-Bonilla, JG; Galindo, M; Calvo-Alen, J; Olive, A; Fernandez-Nebro, A; Menor-Almagro, R; Tomero, E; Horcada, L; Uriarte-Itzazelaia, E; Martinez-Taboada, VM; Andreu, JL; Boteanu, A; Narvaez, J; Bohorquez, C; Montilla, C; Santos, G; Hernandez-Cruz, B; Vela, P; Salgado, E; Freire, M; Hernandez-Beriain, JA; Diez-Alvarez, E; Exposito, L; Fernandez-Berrizbeitia, O; Velloso-Feijoo, ML; Ibanez-Barcelo, M; Lozano-Rivas, N; Bonilla, G; Moreno, M; Raya, E; Quevedo-Vila, VE; Vazquez-Rodriguez, TR; Ibanez-Ruan, J; Munoz-Fernandez, S; Sanchez-Alonso, F; Pego-Reigosa, JM – 2020

Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

Mena-Vazquez, N; Fernandez-Nebro, A; Pego-Reigosa, JM; Galindo, M; Melissa-Anzola, A; Uriarte-Isacelay, E; Olive-Marques, A; Aurrecoechea, E; Freire, M; Tomero, E; Garcia-Villanueva, MJ; Stoye, C; Salas-Heredia, E; Bernal-Vidal, JA; Salgado, E; Blanco, R; Novoa, FJ; Ibanez-Barcelo, M; Torrente-Segarra, V; Narvaez, J; Calvet, J; Morales, CM; Vazquez-Rodriguez, TR; de la Pena, PG; Bohorquez, C; Andreu-Sanchez, JL; Cobo-Ibanez, T; Bonilla, G; Lozano-Rivas, N; Montilla, C; Toyos, FJ; De la Fuente, JLM; Exposito, L; Ruiz-Lucea, ME; Vals, E; Manero-Ruiz, J; Bernal-Vidal, JA; Rua-Figueroa, I – 2020

Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjogren syndrome

Salman-Monte, TC; Sanchez-Piedra, C; Castro, MF; Andreu, JL; Taboada, VM; Olive, A; Rosas, J; Menor, R; Rodriguez, B; Aparicio, AG; Longo, FJL; Manrique-Arija, S; Vadillo, JAG; Barato, SG; Lopez-Gonzalez, R; Galisteo, C; Martin, JG; Lucea, ER; Erausquin, C; Melchor, S; Moreira, B; Raya, E; Pego-Reigosa, JM; Cid, N; Judez, E; Moriano, C; Narvaez, FJ; Corominas, H; Magallon, BG; Astete, CG; Castellvi, I; Bohorquez, C; Loricera, J; Belzunegui, J; Illera, O; Torrente-Segarra, V – 2020

Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

Fernandez-Diaz, C; Castaneda, S; Melero-Gonzalez, RB; Ortiz-Sanjuan, F; Juan-Mas, A; Carrasco-Cubero, C; Casafont-Sole, I; Olive, A; Rodriguez-Muguruza, S; Almodovar-Gonzalez, R; Castellanos-Moreira, R; Rodriguez-Garcia, SC; Aguilera-Cros, C; Villa, I; Ordonez-Palau, S; Raya-Alvarez, E; Morales-Garrido, P; Ojeda-Garcia, C; Moreno-Ramos, MJ; Hernan, MGB; Rodriguez, IH; Lopez-Corbeto, M; Andreu, JL; de Aberasturi, JRDJ; Ruibal-Escribano, A; Exposito-Molinero, R; Perez-Sandoval, T; Lopez-Robles, AM; Carreira-Delgado, P; Mena-Vazquez, N; Urruticoechea-Arana, A; Peralta-Gines, C; Arboleya-Rodriguez, L; Garcia, FJN; Palma-Sanchez, D; Perez, ECC; Maiz-Alonso, O; Alvarez-Rivas, MN; Fernandez-Melon, J; Casasempere, PV; Cabezas-Rodriguez, I; Castellvi-Barranco, I; Gonzalez-Montagut, C; Blanco-Madrigal, J; Del Val-Del Amo, N; Fito, MC; Rodriguez-Gomez, M; Salgado-Perez, E; Garcia-Magallon, B; Hidalgo-Calleja, C; Lopez-Sanchez, R; Fernandez-Aguado, S; Fernandez-Lopez, JC; Castro-Oreiro, S; Serrano-Garcia, I; Garcia-Valle, A; Romero-Yuste, S; Exposito-Perez, L; Perez-Albadalejo, L; Garcia-Aparicio, A; Quillis-Marti, N; Bernal-Vidal, JA; Loricera-Garcia, J; Hernandez, JL; Gonzalez-Gay, MA; Blanco, R – 2020

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F; Galindo-Izquierdo, M; Ovalles, J; Olive-Marques, A; Fernandez-Nebro, A; Calvo-Alen, J; Menor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andres, M; Freire-Gonzalez, M; Soler, GS; Ruiz-Lucea, E; Ibanez-Barcelo, M; Castellvi, I; Galisteo, C; Vila, VQ; Raya, E; Narvaez-Garcia, J; Exposito, L; Hernandez-Beriain, JA; Horcada, L; Aurrecoechea, E; Pego-Reigosa, JM – 2020

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

Calderon-Goercke, M; Castaneda, S; Aldasoro, V; Villa, I; Prieto-Pena, D; Atienza-Mateo, B; Patino, E; Moriano, C; Romero-Yuste, S; Narvaez, J; Gomez-Arango, C; Perez-Pampin, E; Melero, R; Becerra-Fernandez, E; Revenga, M; Alvarez-Rivas, N; Galisteo, C; Sivera, F; Olive-Marques, A; del Buergo, MA; Marena-Rojas, L; Fernandez-Lopez, C; Navarro, F; Raya, E; Galindez-Agirregoikoa, E; Arca, B; Solans-Laque, R; Conesa, A; Hidalgo, C; Vazquez, C; Roman-Ivorra, JA; Loricera, J; Lluch, P; Manrique-Arija, S; Vela, P; De Miguel, E; Torres-Martin, C; Nieto, JC; Ordas-Calvo, C; Salgado-Perez, E; Luna-Gomez, C; de Miera, FJTS; Fernandez-Llanio, N; Garcia, A; Larena, C; Gonzalez-Vela, C; Corrales, A; Varela-Garcia, M; Aurrecoechea, E; Dos Santos, R; Garcia-Manzanares, A; Ortego, N; Fernandez, S; Ortiz-Sanjuan, F; Corteguera, M; Hernandez, JL; Gonzalez-Gay, MA; Blanco, R – 2020

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

Aterido, A; Canete, JD; Tornero, J; Ferrandiz, C; Pinto, JA; Gratacos, J; Queiro, R; Montilla, C; Torre-Alonso, JC; Perez-Venegas, JJ; Nebro, AF; Munoz-Fernandez, S; Gonzalez, CM; Roig, D; Zarco, P; Erra, A; Rodriguez, J; Castaneda, S; Rubio, E; Salvador, G; Diaz-Torne, C; Blanco, R; Dominguez, AW; Mosquera, JA; Vela, P; Sanchez-Fernandez, SA; Corominas, H; Ramirez, J; de la Cueva, P; Fonseca, E; Fernandez, E; Puig, L; Dauden, E; Sanchez-Carazo, JL; Lopez-Estebaranz, JL; Moreno, D; Vanaclocha, F; Herrera, E; Blanco, F; Fernandez-Gutierrez, B; Gonzalez, A; Perez-Garcia, C; Alperi-Lopez, M; Marques, AO; Martinez-Taboada, V; Gonzalez-Alvaro, I; Sanmarti, R; Roura, CT; Garcia-Montero, AC; Bonas-Guarch, S; Mercader, JM; Torrents, D; Codo, L; Gelpi, JL; Lopez-Corbeto, M; Pluma, A; Lopez-Lasanta, M; Tortosa, R; Palau, N; Absher, D; Myers, R; Marsal, S; Julia, A – 2019

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

Lopez-Isac, E; Acosta-Herrera, M; Kerick, M; Assassi, S; Satpathy, AT; Granja, J; Mumbach, MR; Beretta, L; Simeon, CP; Carreira, P; Ortego-Centeno, N; Castellvi, I; Bossini-Castillo, L; Carmona, FD; Orozco, G; Hunzelmann, N; Distler, JHW; Franke, A; Lunardi, C; Moroncini, G; Gabrielli, A; de Vries-Bouwstra, J; Wijmenga, C; Koeleman, BPC; Nordin, A; Padyukov, L; Hoffmann-Vold, AM; Lie, B; Rios, R; Callejas, JL; Vargas-Hitos, JA; Garcia-Portales, R; Camps, MT; Fernandez-Nebro, A; Gonzalez-Escribano, MF; Garcia-Hernandez, FJ; Castillo, MJ; Aguirre, MA; Gomez-Gracia, I; Fernandez-Gutierrez, B; Rodriguez-Rodriguez, L; de la Pena, PG; Vicente, E; Andreu, JL; de Castro, MF; Lopez-Longo, FJ; Martinez, L; Fonollosa, V; Guillen, A; Espinosa, G; Tolosa, C; Pros, A; Rodriguez-Carballeira, M; Narvaez, FJ; Rubio-Rivas, M; Ortiz-Santamaria, V; Madronero, AB; Gonzalez-Gay, MA; Diaz, B; Trapiella, L; Sousa, A; Egurbide, MV; Fanlo-Mateo, P; Saez-Comet, L; Diaz, F; Hernandez, V; Beltran, E; Roman-Ivorra, JA; Grau, E; Alegre-Sancho, JJ; Freire, M; Blanco-Garcia, FJ; Oreiro, N; Witte, T; Kreuter, A; Riemekasten, G; Airo, P; Magro, C; Voskuyl, AE; Vonk, MC; Hesselstrand, R; Proudman, S; Stevens, W; Nikpour, M; Zochling, J; Sahhar, J; Roddy, J; Nash, P; Tymms, K; Rischmueller, M; Lester, S; Vyse, T; Herrick, AL; Worthington, J; Denton, CP; Allanore, Y; Brown, MA; Radstake, TRDJ; Fonseca, C; Chang, HY; Mayes, MD; Martin, J – 2019

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Members

  • Researcher in Charge
    Será Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigación del Instituto y sus Co-IR. Esta categoría puede incluir investigadores muy excepcionales en su disciplina.

Antonio Fernández Nebro

Correo electrónico: afernandezn@uma.es
ORCID
SCOPUS

  • Co-investigator in Charge
    Será Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigación del Instituto y sus Co-IR. Esta categoría puede incluir investigadores muy excepcionales en su disciplina.

Natalia Mena Vázquez

Correo electrónico: natalia.mena.sspa@juntadeandalucia.es 
ORCID
SCOPUS

  • Investigador Asistencial Colaborador
    Será Investigador Asistencial Colaborador el Investigador que no reúne la consideración de Investigador Posdoctoral. Estarán adscritos a un Grupo de Investigación liderado por un IR. Las funciones serán las que le tenga asignada su IR.

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

  • Investigadores posdoctorales y/o junior
    Esta etapa posdoctoral estará restringida a Investigadores del Instituto que tengan el título doctor y no contemplados en los perfiles posteriores. Durante su etapa posdoctoral pueden llegar a liderar proyectos de I+D+i como Investigadores Principales, aunque aún no hayan establecido un nivel significativo de independencia. Además, pueden tener actividades de docencia y/o asistencial más allá de su trabajo de investigación.

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

  • Investigadores predoctorales y/o en formación

    Los investigadores predoctorales y/o en formación serán aquellos investigadores que realizan investigaciones bajo supervisión en una línea de investigación orientada a la resolución de problemas de salud. Incluye aquellos investigadores que están cursando un doctorado (incluyendo a los contratados Río Hortega)

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

  • Personal Técnico

    Los investigadores predoctorales y/o en formación serán aquellos investigadores que realizan investigaciones bajo supervisión en una línea de investigación orientada a la resolución de problemas de salud. Incluye aquellos investigadores que están cursando un doctorado (incluyendo a los contratados Río Hortega)

No results

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.